免疫生物研究所の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/10/16 | 1,059 | 1,065 | 1,039 | 1,051 | +6 | +0.6% | 52,000 |
| 2026/10/15 | 1,058 | 1,070 | 1,045 | 1,045 | -43 | -4% | 109,600 |
| 2026/10/14 | 1,099 | 1,100 | 1,080 | 1,088 | -11 | -1% | 44,500 |
| 2026/10/13 | 1,069 | 1,099 | 1,060 | 1,099 | +27 | +2.5% | 41,800 |
| 2026/10/09 | 1,045 | 1,088 | 1,045 | 1,072 | +10 | +0.9% | 73,500 |
| 2026/10/08 | 1,111 | 1,111 | 1,049 | 1,062 | -57 | -5.1% | 166,300 |
| 2026/10/07 | 1,170 | 1,170 | 1,119 | 1,119 | -51 | -4.4% | 138,000 |
| 2026/10/06 | 1,152 | 1,194 | 1,151 | 1,170 | +14 | +1.2% | 103,000 |
| 2026/10/05 | 1,175 | 1,175 | 1,119 | 1,156 | +11 | +1% | 92,800 |
| 2026/10/02 | 1,173 | 1,184 | 1,125 | 1,145 | -28 | -2.4% | 129,200 |
| 2026/10/01 | 1,200 | 1,200 | 1,164 | 1,173 | -26 | -2.2% | 118,000 |
| 2026/09/30 | 1,154 | 1,210 | 1,145 | 1,199 | +44 | +3.8% | 122,800 |
| 2026/09/29 | 1,177 | 1,177 | 1,141 | 1,155 | -12 | -1% | 72,700 |
| 2026/09/28 | 1,219 | 1,219 | 1,163 | 1,167 | -43 | -3.6% | 130,200 |
| 2026/09/25 | 1,200 | 1,225 | 1,189 | 1,210 | +18 | +1.5% | 126,400 |
| 2026/09/24 | 1,192 | 1,220 | 1,180 | 1,192 | +6 | +0.5% | 196,900 |
| 2026/09/18 | 1,146 | 1,189 | 1,133 | 1,186 | +41 | +3.6% | 189,700 |
| 2026/09/17 | 1,157 | 1,182 | 1,144 | 1,145 | -8 | -0.7% | 142,000 |
| 2026/09/16 | 1,165 | 1,188 | 1,130 | 1,153 | -9 | -0.8% | 143,900 |
| 2026/09/15 | 1,160 | 1,169 | 1,128 | 1,162 | +3 | +0.3% | 137,400 |
| 2026/09/14 | 1,100 | 1,179 | 1,093 | 1,159 | +50 | +4.5% | 141,000 |
| 2026/09/11 | 1,125 | 1,125 | 1,097 | 1,109 | -35 | -3.1% | 101,800 |
| 2026/09/10 | 1,144 | 1,170 | 1,132 | 1,144 | -8 | -0.7% | 102,700 |
| 2026/09/09 | 1,176 | 1,176 | 1,130 | 1,152 | -4 | -0.3% | 186,400 |
| 2026/09/08 | 1,144 | 1,192 | 1,122 | 1,156 | +5 | +0.4% | 293,900 |
| 2026/09/07 | 1,063 | 1,186 | 1,063 | 1,151 | +89 | +8.4% | 517,100 |
| 2026/09/04 | 1,041 | 1,065 | 1,036 | 1,062 | +15 | +1.4% | 52,300 |
| 2026/09/03 | 1,029 | 1,054 | 1,021 | 1,047 | +17 | +1.7% | 67,000 |
| 2026/09/02 | 1,040 | 1,054 | 1,029 | 1,030 | -36 | -3.4% | 105,600 |
| 2026/09/01 | 1,065 | 1,071 | 1,032 | 1,066 | -4 | -0.4% | 114,000 |
| 2026/08/31 | 1,080 | 1,082 | 1,060 | 1,070 | -40 | -3.6% | 122,700 |
| 2026/08/28 | 1,094 | 1,148 | 1,083 | 1,110 | +22 | +2% | 270,800 |
| 2026/08/27 | 1,075 | 1,146 | 1,055 | 1,088 | +37 | +3.5% | 310,400 |
| 2026/08/26 | 1,064 | 1,074 | 1,049 | 1,051 | -13 | -1.2% | 55,800 |
| 2026/08/25 | 1,056 | 1,068 | 1,037 | 1,064 | +4 | +0.4% | 105,000 |
| 2026/08/24 | 1,062 | 1,079 | 1,053 | 1,060 | -20 | -1.9% | 69,700 |
| 2026/08/21 | 1,084 | 1,122 | 1,048 | 1,080 | -18 | -1.6% | 196,200 |
| 2026/08/20 | 1,037 | 1,117 | 1,036 | 1,098 | +99 | +9.9% | 423,100 |
| 2026/08/19 | 1,022 | 1,047 | 992 | 999 | -34 | -3.3% | 119,600 |
| 2026/08/18 | 1,059 | 1,085 | 1,029 | 1,033 | -33 | -3.1% | 121,100 |
| 2026/08/17 | 1,041 | 1,076 | 1,032 | 1,066 | +25 | +2.4% | 146,300 |
| 2026/08/14 | 1,028 | 1,061 | 1,023 | 1,041 | -4 | -0.4% | 96,100 |
| 2026/08/13 | 1,000 | 1,049 | 988 | 1,045 | +46 | +4.6% | 132,500 |
| 2026/08/12 | 997 | 1,019 | 988 | 999 | +3 | +0.3% | 105,400 |
| 2026/08/10 | 998 | 1,040 | 991 | 996 | +56 | +6% | 233,700 |
| 2026/08/07 | 967 | 967 | 929 | 940 | -12 | -1.3% | 113,700 |
| 2026/08/06 | 954 | 971 | 939 | 952 | -8 | -0.8% | 62,500 |
| 2026/08/05 | 959 | 974 | 950 | 960 | +1 | +0.1% | 98,800 |
| 2026/08/04 | 947 | 968 | 943 | 959 | +28 | +3% | 65,300 |
| 2026/08/03 | 925 | 949 | 911 | 931 | -4 | -0.4% | 39,900 |
1~
50
件表示中 / 4046件
類似銘柄と比較する
現在ご覧いただいている「免疫生物」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 免疫生物 | 105,100円 | +8.3% | +7.3% | 0.71% | 28.21倍 | 5.31倍 |
|
体外診断薬や研究用抗体製販・受託。遺伝子組み換えカイコは細胞培養足場材や化粧品展開 |
| ステムリム | 16,400円 | - | - | 0.00% | - | 2.47倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 窪田製薬 | 6,200円 | +90.5% | - | 0.00% | - | 6.28倍 |
|
眼科医薬ベンチャー。近視矯正「クボタメガネ」の開発に注力、眼疾患治療薬の開発は中断状態 |
| 仁 丹 | 221,900円 | -2.3% | -9.4% | 2.93% | 17.20倍 | 0.70倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ケイファーマ | 73,200円 | - | - | 0.00% | - | 11.01倍 |
|
慶応大学発ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
市場注目の銘柄
チャート関連のコラム